Temsirolimus and fatigue Patient Reports February 10, 2010
Temsirolimus Side Effects Report #6047145-0
Temsirolimus side effect was reported by a Physician from UNITED STATES on Jan 09, 2009. Female patient, 73 years of age, weighting 141.1 lb, was diagnosed with malignant peritoneal neoplasm, urinary tract infection
and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: asthenia, blood pressure systolic increased, dehydration, ear pain, fatigue, haematocrit decreased, haemoglobin decreased, hypokalaemia, lung infiltration. Temsirolimus dosage: unknown. During the same period patient was treated with COUMADIN, LASIX, COMPAZINE, ATARAX, MACROBID, ZOFRAN. Patient was hospitalized. Patient recovered.Temsirolimus Side Effects Report #5534786-X
Temsirolimus side effect was reported by a Physician from UNITED STATES on Nov 30, 2007. Male patient, 69 years of age, weighting 175.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: abdominal abscess, blood glucose increased, confusional state, dysphagia, escherichia sepsis, fatigue, muscular weakness, oral intake reduced, soft tissue necrosis. Temsirolimus dosage: 75 MG OVER 30 MINUTES. During the same period patient was treated with ALLOPURINOL, HYZAAR, TOPROL, OMEPRAZOLE, DILTIAZEM HYDROCHLORIDE, ASPIRIN, TYLENOL. Patient was hospitalized. Patient died on 02/05/2007.
Temsirolimus Side Effects Report #5809155-5
Temsirolimus side effect was reported by a Physician from UNITED STATES on July 09, 2008. Male patient, 69 years of age, weighting 175.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: abdominal abscess, blood glucose increased, confusional state, dysphagia, escherichia sepsis, fatigue, hypophagia, muscular weakness, soft tissue necrosis. Temsirolimus dosage: 75 MG OVER 30 MINUTES. During the same period patient was treated with ALLOPURINOL, HYZAAR, TOPROL, OMEPRAZOLE, DILTIAZEM HYDROCHLORIDE, ASPIRIN, TYLENOL. Patient was hospitalized. Patient died on 02/05/2007.
Temsirolimus Side Effects Report #5129924-7
Temsirolimus side effect was reported by a Physician from UKRAINE on Sept 21, 2006. Female patient, 76 years of age, was diagnosed with breast cancer
and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: band neutrophil percentage increased, cardiac disorder, fatigue, haemoglobin decreased, infection
, lobar pneumonia, monocyte percentage decreased, poisoning
, sputum discoloured. Temsirolimus dosage: 30 MG D1-D5 ORAL. During the same period patient was treated with LETROZOLE, LISINOPRIL AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.Temsirolimus Side Effects Report #5129924-7
Temsirolimus side effect was reported by a Consumer or non-health professional from UKRAINE on Sept 21, 2006. Female patient, 76 years of age, was diagnosed with breast cancer
and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: band neutrophil percentage increased, cardiac disorder, fatigue, haemoglobin decreased, infection
, lobar pneumonia, monocyte percentage decreased, poisoning
, sputum discoloured. Temsirolimus dosage: 30 MG D1-D5 ORAL. During the same period patient was treated with LETROZOLE, LISINOPRIL. Patient was hospitalized. Patient recovered.Temsirolimus Side Effects Report #5609040-8
Temsirolimus side effect was reported by a Physician from SWEDEN on Jan 25, 2008. Female patient, 61 years of age, was diagnosed with psoriasis and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: candidiasis, clostridial infection, fatigue, pyothorax, pyrexia, sputum purulent. Temsirolimus dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.
Temsirolimus and fatigue 